Komori
V

VITAL KSK HOLDINGS,INC.

3151Trading & WholesaleSmall cap
1,542JPY-1.0%
★ Watch (sign-up required)
Price history
¥1,542Latest+101.6%
Drag across the chart to measure the move between two points.Delayed 15 minutes · monthly closing basis
Business overview

The Group aims to ensure stable supply across pharmaceutical distribution and related services and provide community-based healthcare through a business structure centered on pharmaceutical wholesaling and comprising five segments: pharmaceutical wholesaling, pharmacy operations, veterinary pharmaceutical wholesaling, pharmaceuticals, and nursing-care rentals and other businesses. The Group comprises 23 consolidated companies and 4 equity-method affiliates, with operations conducted primarily through its pharmaceutical wholesaling business. Major subsidiaries include Vitalnet and KSK, and key financial information such as net sales, ordinary profit and net income is disclosed. The filing also sets out policies including the medium-term management plan, sustainability and dividends, together with extensive information on regional sales, the corporate structure, directors and major shareholders.

Recurring subjects
No threads yetThis company's filings have not been read yet. We are adding them progressively.
Companies sharing a theme
Loading
Documents
See all timely disclosuresSee all statutory filings
News
See all news
Key numbersShowing 8 of 20
PER
222.94How many years of earnings it would take to buy the stock. The market average is generally considered to be around 15.
PBR
0.69How many times the company's net assets? Around 1x is generally considered a benchmark.
ROE
0.3%Earning power. A figure above 10% is generally considered good.
Dividend yield
0.0%The annual dividend as a percentage of the share price.
Market capitalization
¥80bnShare price × number of shares. The value of the entire company.
Equity ratio
35.5%The proportion of assets funded by money that does not have to be repaid.
Operating margin
0.4%The percentage of revenue remaining from the company’s core business.
Revenue growth (3 years)
2.3%The average annual growth in sales over the past three years.
What to watch next
Progress on construction of the Isehara Logistics Center (the 3PL operations of Vitalnet/Vital KSK) and disclosure of preparations for its launch toward operations in fiscal 2026
By the end of FY2026Impact HighLikelihood Medium
Confirmation of the start of operations and earnings contribution following the logistics-capacity investment at the Hanshin Office (¥6,000 million investment; completion scheduled for around March 2027 or during the period set out in the plan)
Around March 2027Impact MediumLikelihood Medium
Progress in clinical trials under the unapproved-drug introduction support program (ferric maltol for pulmonary arterial hypertension), including the next milestone now that the clinical-trial agreement and investigational-drug placement have been completed
Sequentially as the clinical trial progresses (specific dates to be disclosed)Impact HighLikelihood Low
The outcome of competition-law regulatory action in the animal-healthcare business, including the Japan Fair Trade Commission’s on-site inspection related to Agro Japan, and whether corrective measures or penalties are imposed
Going forward (outcome not yet confirmed)Impact HighLikelihood Low
Continuation of share buybacks and the company’s dividend policy, including DOE and total payout ratio targets
Quarterly to full yearImpact MediumLikelihood High
What to watch next
Loading
Who owns itTop holders total 37.5%
Listed holders 37.5%Everyone else 62.5%
合同会社MH10.09%
The Master Trust Bank of Japan (Trust Account)7.92%
STATE STREET BANK AND TRUST COMPANY 5051032.91%
Suzuki Ken (鈴木 賢)2.85%
ケーエスケー従業員持株会2.63%
Custody Bank of Japan, Ltd. (Trust Account).2.52%
㈲クエコ2.44%
鈴木 宏一郎2.12%
2 other listed holders4.06%
Who owns it
HolderOwnership (%)
合同会社MH10.09
The Master Trust Bank of Japan (Trust Account)7.92
STATE STREET BANK AND TRUST COMPANY 5051032.91
Suzuki Ken (鈴木 賢)2.85
ケーエスケー従業員持株会2.63
Custody Bank of Japan, Ltd. (Trust Account).2.52
㈲クエコ2.44
鈴木 宏一郎2.12
2 other listed holders4.06
This company's documents
Filings
Timely disclosures
Threads